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This  study  examined  the  expression  of  growth  and  differentiation  factor  9 (GDF-9)  in
caprine ovarian  follicles,  and  the  effect  of GDF-9  with  or  without  FSH  on  the  in  vitro  culture
of preantral  follicles.  To  evaluate  the  expression  of GDF-9  in Experiment  1, follicles  were
recovered  from  32  goat  ovaries  and  the  total  RNA isolated  and  transcribed  for  real-time
polymerase  chain  reaction  (PCR).  Experiments  2 and  3  each  used  a  further  32  goat  ovaries
to provide  preantral  follicles  of  ≥150  m.  These  follicles  were  isolated  and  cultured  indi-
vidually  in  100 L  drops.  In each  experiment  at least  45 follicles  were  used  per  treatment.
Every  6 days,  follicles  were  evaluated  for viability,  antrum  formation  and  growth  rate.  At
the  end  of the  culture  period,  oocytes  were  submitted  to in  vitro  maturation  (IVM),  viability
tests  and  chromatin  evaluation.  In Experiment  2, follicles  were  cultured  in a basal  medium
(control)  or  this  medium  supplemented  with  GDF-9  at a concentration  of 100  ng/mL  (GDF-9
100) or  200  ng/mL  (GDF-9  200).  The  same media  were  used  in Experiment  3,  supplemented
with  recombinant  FSH  at  a level  of  100  ng/mL  from  day  0, 500 ng/mL  from  day  6  to  12  and
1000 ng/mL  from  day  12  to 18  of  culture  to  form  the  three  treatments:  control  FSH,  GDF-9
(100) plus  FSH  and  GDF-9  (200)  plus  FSH.  Relative  GDF-9  expression  (Experiment  1)  was
greater in the  secondary  (18 units)  than  the  primordial  (1 unit)  and  the  primary  (1 unit) pre-
antral  follicles  (P  < 0.05).  In  the  antral  follicles,  GDF-9  expression  was signiﬁcantly  higher
in the  cumulus–oocyte  complexes  COC’s  <  3 mm  (1.6  units)  than  those  of >3 mm  diame-
ter (1  unit;  P <  0.05),  and in  COC’s  <  3 mm  and  >3 mm  (319.2  and  200.1  units,  respectively),
compared  to their  respective  granulosa  and  theca  cells  (1 unit  for each  category,  P <  0.05).
In  Experiment  2, GDF-9  supplementation  signiﬁcantly  improved  the  survival  of the  follicles
(60.8%,  66.0%  and  77.4%  for  the  control,  GDF-9  100  and  GDF-9  200,  respectively;  P <  0.05),
follicular growth  rate  and  antrum  formation  following  18  days  of  culture.  Oocyte  survival
was approximately  100%  in  all  treatments.  More  oocytes  were  submitted  to  IVM  from  GDF-
9  100  (78.0%;  P < 0.05),  compared  to GDF-9  200  (48.1%),  but no  suitable  oocytes  could  be
retrieved  from  the control  (58.8%).  The  proportion  of  oocytes  showing  a  resumption  of
meiosis,  was not  signiﬁcantly  different  between  treatments  (41.4%,  35.9%  and  36.0%  for
the control,  GDF-9  100  and  GDF-9  200,  respectively).  The  addition  of  GDF-9  to  the  media
supplemented  with  FSH  (Experiment  3) did not  signiﬁcantly  affect  any  of  the  variables
studied.  The  proportion  of  oocytes  submitted  to IVM  in  Experiment  3 was  53.3%,  56.5% and
63.8% for the control  FSH,  GDF-9  100  plus  FSH  and  GDF-9  200  plus  FSH,  respectively  (no
statistical  differences).  The resumption  of  meiosis  was  75.0%,  60.9%  and  60.7%  for  the control
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FSH,  GDF-9  100  plus  FSH  and  GDF-9  200  plus  FSH,  respectively  (NS).  The  occurrence  of
metaphase  II was  very  low  in both  experiments.  It was concluded  that the  supplementation
of  a  basal  medium  with  GDF-9  had  a positive  effect  on  the  survival  and  development  of
ollicles,  but had  no  real  effect  in  the presence  of  FSH.
2.2. Experiment 1: GDF-9 messenger RNA expression in caprine ovariescaprine preantral  f
1. Introduction
The study of folliculogenesis is of great importance
in terms of the optimization of the female gameto-
genic potential, as 90–95% of the ovarian population
resorts under the preantral category, and most folli-
cles (99.9%) are eliminated through follicular atresia
(Figueiredo et al., 2007). However, the initial develop-
ment of folliculogenesis is very complex and involves the
action of growth factors that could either be paracrine
or autocrine, and may  be exchanged between the oocyte,
theca and granulosa cells (Eppig, 2001; Fortune, 2003;
Van den Hurk and Zhao, 2005). Growth factors, as well
as their receptors, are expressed in a stage-speciﬁc form
and act synchronically to promote stimulatory and/or
inhibitory effects. These are then responsible for the
regulation of ovarian follicular development. Addition-
ally, such substances act on the development of the
oocyte competence, regarding fertilization and subsequent
embryogenesis (Van den Hurk et al., 2000; Eppig, 2001;
Matzuk et al., 2002). Certain studies have provided evi-
dence regarding the role of several growth factors in
folliculogenesis. Among the main factors involved in ovar-
ian folliculogenesis, the Growth and Differentiation Factor
9 (GDF-9), must be highlighted.
GDF-9 belongs to the super family of beta-transforming
growth factors (TGF-) and regulates the differenti-
ation, proliferation and apoptosis of follicular cells.
Such processes are essential for embryonic development,
organogenesis, bone formation and reproduction (Chang
et al., 2002). The activity of GDF-9 is mediated by the for-
mation of a heterodimeric complex and its type I (ALK-5)
(Mazerbourg et al., 2004) and II (BMPRII) receptors (Vitt
et al., 2002). In the ovaries, GDF-9 has been expressed
in the oocytes of primordial follicles of sheep and cows
(Bodensteiner et al., 1999). In women (Aaltonen et al.,
1999), mice (McGrath et al., 1995; Dube et al., 1998; Elvin
et al., 1999) and rats (Hayashi et al., 1999; Jaatinen et al.,
1999), the expression of GDF-9 begins at the primary fol-
licle stage. In goats, the polymerase chain reaction (PCR)
technique revealed the presence of GDF-9 mRNA in primor-
dial, primary and secondary follicles, oocytes and granulosa
cells of antral follicles and in the corpus luteum (Silva et al.,
2004). In the ovine ovary, the expression of the BMPRII and
ALK-5 receptors has been shown to increase with follic-
ular growth (Qin Chen et al., 2009). These elements have
previously been found in the granulosa cells of follicles
from the primary to late antral stage (Souza et al., 2002).
In goats, the BMPRII, BMPR1A (ALK-3) and BMPR1B (ALK-
6) receptors have been identiﬁed in primordial, primary
and secondary preantral follicles, oocytes, granulosa and
theca cells of antral follicles and in CL’s (Silva et al., 2004).
The presence of GDF-9 receptors in the ovary demonstrates
their importance in follicular development. Additionally,© 2011 Elsevier B.V. 
the elimination of the GDF-9 encoding gene in mice, has
conﬁrmed that GDF-9 is important for mouse follicular acti-
vation and growth (Barnett et al., 2006).
When used for in vitro culture of preantral follicles of
rats, GDF-9 promoted the early transition of these folli-
cles into the antral stage and suppressed follicular atresia
(Orisaka et al., 2006). Martins et al. (2008) veriﬁed that in
goats this factor maintains its viability and follicular ultra-
structure and promotes the growth of preantral follicles
that were cultured in ovarian tissue (in situ). Similarly,
Hayashi et al. (1999) observed that the use of GDF-9, alone
or in combination with FSH, favored the in vitro growth of
secondary preantral follicles, isolated from mouse ovaries.
Research has shown that FSH mediates the action of GDF-
9 action, and may  be mediated by FSH in cultures of
oocyte–granulosa cell complexes in mice (Thomas et al.,
2005) and granulosa cells isolated from sheep (Qin Chen
et al., 2009).
Although GDF-9 is an essential factor for follicular devel-
opment, there have been no studies focussed on the effect
of this factor, with or without FSH, on the culture of pre-
antral follicles isolated from caprine ovaries. In addition,
even though GDF-9 expression has been recorded in the
ovaries of goats, the quantiﬁcation of speciﬁc mRNA in dif-
ferent follicular categories has not been performed. Thus,
this trial was aimed at quantifying GDF-9 expression in
different categories and compartments (cumulus–oocyte
complexes – COC’s – and mural cells) of the ovarian folli-
cles, and evaluating the effect on in vitro culture of caprine
preantral follicles, with or without FSH.
2. Materials and methods
This research was  divided into three sequential experiments: the
quantiﬁcation of GDF-9 mRNA in caprine ovarian follicles (Experiment 1),
and the in vitro culture of caprine preantral follicles in medium supple-
mented with GDF-9 (100 ng/mL or 200 ng/mL), without FSH (Experiment
2)  and with FSH (Experiment 3).
2.1. Reagents and ovarian tissue
Unless otherwise speciﬁed, the culture medium and all other reagents
used in this study were acquired from the Sigma Chemical Co. (St. Louis,
MO,  USA).
Ovaries were collected from adult mixed-breed goats (Capra hircus)
from  a local slaughterhouse. A total of 96 caprine ovaries, 32 per experi-
ment, were used for the three experiments. Immediately after slaughter,
the ovaries were washed in 70% alcohol and then twice with Minimum
Essential Medium (MEM), buffered with HEPES (MEM-HEPES) and sup-
plemented with penicillin (100 g/mL) and streptomycin (100 g/mL).
Subsequently, all ovaries were transported to the laboratory within an
hour (at 4 ◦C) (Chaves et al., 2008).
Open access under the Elsevier OA license. Sixteen caprine ovaries were used for the isolation of primordial, pri-
mary and secondary follicles. From the other 16 ovaries, COC’s and mural
cells (granulosa and theca cells) were collected from small (<3 mm)  and
large (>3 mm)  antral follicles.
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Primordial, primary and secondary ovarian follicles were isolated
sing a physical procedure (Lucci et al., 1999), performed within 2 h after
ollection. After isolation, the follicles were allocated according to their
ategory, into groups of 10. From the second group of ovaries, selected
rom the follicular content of antral follicles, compact COC’s were aspi-
ated and grouped as smaller or larger than 3 mm in diameter (Van Tol and
evers, 1998). To collect the mural theca and granulosa cell complexes,
mall and large antral follicles were isolated from the ovarian stroma,
sing 26 gauge needles, and then bisected. The COC’s and mural theca and
ranulosa cell complexes were divided into groups of 10. All the samples
ere stored in microcentrifuge tubes at −80 ◦C, until RNA extraction.
Total RNA extraction was performed using a Trizol puriﬁcation kit,
ccording to the manufacturer’s instructions. Before reverse transcrip-
ion, the RNA samples were incubated for 5 min  (at 70 ◦C), and then
ooled on ice. Reverse transcription was performed in a total volume of
0 l, containing 10 l of the RNA sample, 4 l of reverse transcriptase 5×
uffer, 8 units of RNAseout, 150 units of reverse transcriptase Superscript
II, 0.036 U random primers, 10 mM DTT and 0.5 mM dNTP. The mix  was
ncubated at 42 ◦C for 1 h, 80 ◦C for 5 min, and then stored at −20 ◦C. The
egative controls were prepared under the same conditions, but reverse
ranscriptase was  not included. The primers and all of the other products
ere acquired from Invitrogen (São Paulo, Brazil).
GDF-9 mRNA quantiﬁcation was performed using SYBR Green.
he PCR mix  contained 1 l of cDNA template, 7.5 l of SYBR Green
aster Mix  (PE Applied Biosystems, Foster City, CA, USA), 5.5 l
ltrapure water and 0.5 M of primer. The primers were designed to
mplify mRNA from GDF-9 (forward 5′-ACAACACTGTTCGGCTCTTCACCC-
′ and reverse 5′-CCACAACAGTAACACGATCCAGGTT-3′) and two
ousekeeping genes: GAPDH (forward 5′-TGTTTGTGATGGGCGTGAACCA-
′ and reverse 5′-ATGGCGTGGACAGTGGTCATAA-3′) and -actin
forward 5′-ACCACTGGCATTGTCATGGACTCT-3′ and reverse 5′-
CCTTGATGTCACGGACGATTTCC-3′) used as endogenous controls
or  the normalization of gene expression. The cycle proﬁle for the ﬁrst
CR step was an initial denaturation and polymerase activation for
5  min  at 94 ◦C, followed by 40 cycles of 15 s at 94 ◦C, 30 s at 60 ◦C and
5  s at 72 ◦C. Final extension was performed for 10 min  at 72 ◦C. All
f  the reactions were performed using a Real Time PCR Mastercycler
Eppendorf, Germany). The delta-delta Ct (threshold cycle) method
as used to transform the Ct values into normalized levels of relative
xpression (Livak and Schmittgen, 2001).
.3. Preantral follicle isolation and selection
Fine fragments of the ovarian cortex (1–2 mm thick) were obtained
ith the aid of a sterile scalpel blade. The fragments were placed into the
ragmentation medium, MEM-HEPES. The preantral follicles (≥150 m)
ere then visualized under a stereo-microscope (SMZ 645 Nikon, Tokyo,
apan) and manually microdissected, using 26 gauge needles, attached
o  1 mL  syringes. Only follicles with visible oocytes surrounded by two
r more layers of granulosa cells, with an intact basal membrane and
ithout an antral cavity, were selected for culture. For Experiment
 and 3, 8 ovaries were processed at a time, resulting in one repli-
ate for each treatment, and 4 replicates being performed on different
ays.
.4. Experiment 2: caprine preantral follicle culture with GDF-9 (basic
edium without FSH)
After selection, follicles were individually cultured in 100 L culture
edium, in Petri dishes (60 mm × 15 mm,  Corning, USA), under mineral oil
or 18 days at 39 ◦C and 5% air CO2. The basic culture medium consisted of
-MEM (pH 7.2–7.4), supplemented with 3 mg/mL  bovine serum albumin
BSA), ITS (insulin 10 g/mL, transferrin 5.5 g/mL and selenium 5 ng/mL),
 mM glutamine, 2 mM hypoxanthine and 50 g/mL ascorbic acid without
control) or with GDF-9 at concentrations of 100 ng/mL (GDF-9 100) or
00  ng/mL (GDF-9 200). For each treatment, at least 50 follicles were used.
very 2 days, 60 L of the -MEM medium was  replaced.
.5. Experiment 3: caprine preantral follicle culture with GDF-9 (basic
edium with FSH)
In this experiment, the basic culture medium was the same as that
sed in Experiment 2, except for the sequential addition of recombinant
SH: 100 ng/mL from day 0 (D0) to day 6 (D6), 500 ng/mL from D6 to day 12esearch 100 (2011) 169– 176 171
(D12) and 1000 ng/mL from D12 to day 18 (D18) of culture. Total medium
replacements were performed on days 6 and 12 of culture and partial
replacements performed on the other days. The preantral follicles were
randomly isolated and distributed between the treatments, i.e. the control
FSH  (only sequential FSH) or supplemented with 100 and 200 ng/mL of
GDF-9 (GDF-9 (100) FSH and GDF-9 (200) FSH, respectively), and at least
45  follicles used in each treatment. The follicles were cultured for 18 days
under the same conditions, as previously described for Experiment 2.
2.6. Morphological evaluation of follicular development
The ovarian follicles were classiﬁed as normal or degenerated, based
on  their morphological characteristics. The latter includes irregularities
in  the contour of the basal membrane, or the oocyte and darkening of the
oocyte and the surrounding granulosa cells. On days 0, 6, 12 and 18, the
normal follicles were measured using an ocular micrometer (100× magni-
ﬁcation), attached to a stereomicroscope (SMZ 645 Nikon, Tokyo, Japan).
Two perpendicular measurements were performed. The daily increase
in  follicular diameter was  calculated as follows: the ﬁnal normal follic-
ular  diameter subtracted from the normal follicular diameter on day 0,
divided by the number of culture days. Once a translucent cavity was
visible between the granulosa cells, the antrum was considered to be
formed.
2.7. In vitro maturation (IVM) of oocytes from preantral follicles grown
in  vitro
At the end of the culture period, the oocytes were recovered from
the  follicles, using 26 gauge needles. Oocytes were then washed twice in
TCM199 medium, buffered with HEPES (TCM199-HEPES) and recorded to
include the zona pellucida, as described for the follicles. It was impor-
tant to note that only oocytes with a diameter of ≥110 m were used
for the maturation procedures. After that, the oocytes were cultured
in  TCM199, supplemented with 0.5 g/mL FSH, 5 g/mL LH, 1 g/mL
17-estradiol, 10 ng/mL recombinant Epidermal Growth Factor (EGF),
0.911 mmol/L pyruvate, 100 mol/L cysteamine, 50 ng/mL recombinant
Insulin-like Growth Factor I (IGF-I) and 1% BSA. The oocytes were grouped
into the different treatment groups and cultured in 100 L of medium on
culture dishes (60 mm × 15 mm), under mineral oil for a period of 40 h in
an  incubator, at 39 ◦C, with 5% air CO2.
2.8. Viability evaluation and oocyte chromatin conﬁguration
A  ﬂuorescence microscopy was used to analyze the viability of the
oocytes isolated from the caprine preantral follicles classiﬁed as mor-
phologically normal under the stereomicroscope, after 18 days of culture.
Brieﬂy, the oocytes were incubated in 100 L TCM-HEPES, supplemented
with 4 M calcein-AM, 2 M ethidium homodimer-1 (Molecular Probes,
Invitrogen, Karlsruhe, Germany), and 10 M Hoechst 33342 (Sigma,
Deisenhofen, Germany) at 37 ◦C, for 15 min. After incubation, the oocytes
were washed three times with TCM-HEPES and evaluated under a ﬂuo-
rescence microscope (Nikon, Eclipse 80i, Tokyo, Japan). The oocytes with
cytoplasm marked by calcein-AM (green) were considered to be viable
and those that had chromatin marked with ethidium homodimer-1 (red)
were considered to be degenerated (DEG). Hoechst was used to analyze
the  oocyte chromatin conﬁguration by evaluation of the intact germinal
vesicle (GV), germinal vesicle breakdown (GVBD) or metaphase II (MII)
stage.
2.9. Statistical analysis
Data referring to the GDF-9 mRNA expression in primordial, primary
and secondary follicles were analyzed using the Kruskal–Wallis test (SAS,
1999).  The t-test was  used for paired comparisons of RNA expression in
the small and large antral follicles.
Data regarding the follicular survival, antrum formation and meiosis
restart after in vitro culture were expressed as a percentage, and compared
using the Chi-squared test. The data on the follicular diameter and growth
rate after culture did not have the homogeneity of variance, and were
thus compared using the non-parametric Kruskal–Wallis test (SAS, 1999).
The results were expressed as mean values ± standard error of the mean
(SEM). All differences were considered signiﬁcant at a conﬁdence level of
P  < 0.05.
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Fig. 1. Relative mRNA expression of GDF-9 in goat ovarian follicles (mean + SEM). (a) Primordial, primary and secondary follicles, (b) COC’s from small and
large  antral follicles, (c) granulosa/theca cells of small and large antral follicles, (d) COC’s and granulosa/theca cells of small antral follicles, and (e) COC’s
rences band  granulosa/theca cells of large antral follicles. *Indicates that the diffe
3. Results
3.1. Experiment 1: GDF-9 mRNA expression in caprine
ovaries
Quantiﬁcation of GDF-9 mRNA expression showed that
the level of relative expression recorded in the secondary
follicles, was signiﬁcantly greater than those observed in
the primordial and primary follicles (P < 0.05; Fig. 1a). GDF-
9 mRNA expression in the COC’s from small antral follicles
was signiﬁcantly greater than the expression observed in
those recorded from large antral follicles (P < 0.05; Fig. 1b).
The difference in expression of GDF-9 in the granulosa or
theca cells was the small and not signiﬁcant (Fig. 1c). The
expression of mRNA in granulosa/theca cells from both
small (Fig. 1d) and large (Fig. 1e) follicles was minimaletween variants within a ﬁgure are signiﬁcant, P < 0.05.
and signiﬁcantly lower (P < 0.05) than that occurring in the
respective COC’s.
3.2. Experiment 2: caprine preantral follicle culture with
GDF-9 (basic medium without FSH)
3.2.1. Follicular and oocyte survival
Follicular viability declined progressively from day 0
and was signiﬁcantly lower by day 12 for all treatments
(P < 0.05; Fig. 2). Viability decreased at a slower rate for the
GDF-9 (200) treatment than the control and GDF-9 (100),
which recorded a signiﬁcantly lower (P < 0.05) viability at
day 0, compared to day 6 of culture. At day 18 the viability
of follicles cultured on GDF-9 (200) was  80.8% and signif-
icantly higher than the control (60.8%) and GDF-9 (100)
(66%).
A.P. Almeida et al. / Small Ruminant Research 100 (2011) 169– 176 173
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Table 2
Follicular diameter (m) of preantral follicles isolated from goats with
normal morphology after culture in vitro (culture medium without
FSH), in the absence or presence of different concentrations of GDF-9
(100 ng/mL or 200 ng/mL) for 18 days.
Treatment Day 0 Day 6 Day 12 Day 18
Control 205.2ae 315.9ad 442.4bc 483.9bc
GDF-9 (100) 224.7af 333.9ae 487.7ad 564.3ac
GDF-9 (200) 217.6ade 335.8ad 477.8adc 542.7abc
Different superscripts (ab) indicate that differences between treatmentsig. 2. Survival of goat isolated preantral follicles cultured in vitro (culture
edium without FSH) for 18 days in the absence or presence of GDF-9 at
oncentrations of 100 ng/mL or 200 ng/mL.
Oocyte survival was similar for all treatments, with 98%
f the control oocytes and 100% the GDF-9 (100) and the
DF-9 (200) oocytes marked with calcein-AM when visu-
lized under a ﬂuorescence microscope.
.2.2. Antral cavity formation
The rate of antrum formation was signiﬁcantly higher
or GDF-9 (100) (78%) and GDF-9 (200) (62.3%) treatment
han for the control (43.1%), on day 6 of culture. By day
2 of culture, the proportion of follicles achieving antrum
ormation were at or near the peak values recorded on day
8 (control 80.4%, GDF-9 (100) 92% and GDF-9 (200) 84.9%
NS; Table 1).
.2.3. Follicular growth
Follicular diameter continued to increase until day 18 of
ulture reaching 483.9 m for the control group, which was
igniﬁcantly lower (P < 0.05) than the 564.3 m recorded
or the GDF-9 (100) and 542.7 m for the GDF-9 (200)
roup (Table 2). These differences were reﬂected by the cal-
ulated daily growth rate which was signiﬁcantly higher
P < 0.05) at 18.4 ± 11.1 m/d  for the GDF-9 (100), com-
ared to the control (14.3 ± 10.3 m/d) and similar to that
f the GDF-9 (200) group (17.1 ± 8.9 m/d).
.2.4. Ability to restart meiosis in oocytes grown in vitro
ith GDF-9
The proportion of COC’s suitable for submission to IVM
≥110 m)  at day 18 of follicle culture was 78.0% for GDF-9
100) and signiﬁcantly higher (P < 0.05) than for the control
able 1
ercentage of antrum formation in goat preantral follicles goat strains
ultured in vitro (culture medium without FSH), in the absence or presence
f different concentrations of GDF-9 (100 ng/mL or 200 ng/mL) for 18 days.
Treatment Day 0 Day 6 Day 12 Day 18
Control 0.0ae 43.1bd 78.4ac 80.4ac
GDF-9 (100) 0.0ad 78.0ac 92.0ac 92.0ac
GDF-9 (200) 0.0ae 62.3ad 83.0ac 84.9ac
ifferent superscripts (ab) indicate that differences between treatments
ithin days are signiﬁcantly different; P < 0.05. Different superscripts
cde) indicate that differences between days within treatments are sig-
iﬁcantly different; P < 0.05.within days are signiﬁcantly different; P < 0.05. Different superscripts
(cdef) indicate that differences between days within treatments are sig-
niﬁcantly different; P < 0.05.
(58.8%) and GDF-9 (200) groups (48.1%). The rate of meiotic
resumption (GVBD) in the control, GDF-9 (100) and GDF-
9 (200) was, respectively, 41.4%, 35.9% and 36%, with the
differences between treatments not being signiﬁcant. The
metaphase II stage was  recorded in 3.3% of the control, 2.6%
of the GDF-9 (100) and zero for the GDF-9 groups (200)
(Fig. 3c and d).
3.3. Experiment 3: caprine preantral follicle culture with
GDF-9 (basic medium with FSH)
3.3.1. Follicular and oocyte survival
The proportion of normal follicles decreased continu-
ously in all treatments until day 18 of culture, reaching
values of 57.8% for the control FSH, 54.4% for the GDF-9
(100) FSH and 66% for the GDF-9 (200) FSH (NS) treatment
groups (Fig. 4).
Oocyte survival, as indicated by calcein-AM staining,
was 100% for the control, 88.5% for GDF-9 (100) FSH and
93.3% for GDF-9 (200) FSH (NS) treatments.
3.3.2. Antral cavity formation
Antrum formation was rapid up to day 6 of culture in
all treatments (Table 3). Thereafter, development slowed
and reached a peak, or near peak value by day 12 in all
treatments. The values for antrum formation were 82.2%
in the control, 74% for the GDF-9 (100) FSH and 74.5% for
the GDF-9 (200) treatments at day 18 of culture. None of
the differences between treatments within days of culture
were signiﬁcant.
3.3.3. Follicular growth
Follicular diameter increased steadily in all treatments,
reaching a peak value of 534 m for GDF-9 (100) FSH on day
12 of culture and peak values for the control FSH (478.6 m)
and GDF-9 (200) FSH (554,1 m)  on day 18 of culture
Table 3
Percentage of antrum formation in goat preantral follicles cultured in vitro
(culture medium with FSH), in the absence or presence of different con-
centrations of GDF-9 (100 ng/mL or 200 ng/mL), for 18 days.
Treatment Day 0 Day 6 Day 12 Day 18
Control 0.0c 53.3b 80.0a 82.2a
GDF-9 (100) 0.0c 67.4a 73.9a 73.9a
GDF-9 (200) 0.0c 61.7a 74.5a 74.5a
Different superscripts (abc) indicate that differences between days within
treatments are signiﬁcantly different; P < 0.05.
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e breakdown (GVBD) (b) and metaphase II (MII) (c) after staining with Hoechst
Table 4
Follicular diameter (m) of preantral follicles isolated from goats with
normal morphology after culture in vitro (culture medium with FSH), in
the absence or presence of different concentrations of GDF-9 (100 ng/mL
or  200 ng/mL) for 18 days.
Treatment Day 0 Day 6 Day 12 Day 18
Control 215.8c 327.5b 427.7a 478.6a
GDF-9 (100) 232.2c 361.0b 534.0a 528.6a
d c b aFig. 3. Oocyte showing intact germinal vesicle (GV) (a), germinal vesicl
33342,  bright ﬁeld image of MII  (d) (400× magniﬁcation).
(Table 4). No signiﬁcant differences were recorded between
treatments within any day of culture. The daily growth
rates achieved in the control (14.2 ± 8.2 m/d) and GDF-
9 (200) FSH (13.0 ± 9.7 m/d) groups were signiﬁcantly
higher than for the GDF-9 (100) FSH (7.1 ± 10.6 m/d)
treatment.3.3.4. Ability to restart meiosis in oocytes grown in vitro
with GDF-9
The percentage of oocytes deemed suitable for IVM
(≥110 m)  in the control FSH (53.3%), GDF-9 (100) FSH
Fig. 4. Survival of goat isolated preantral follicles cultured in vitro (culture
medium with FSH) for 18 days, in the absence or presence of GDF-9 at
concentrations of 100 ng/mL or 200 ng/mL.
GDF-9 (200) 225.5 330.8 474.9 554.1Different superscripts (abcd) indicate that differences between days
within treatments are signiﬁcantly different; P < 0.05.
(56.5%) and GDF-9 (200) FSH (63.8%) did not differ among
treatments. Similar results were observed for oocytes
exhibiting GVBD (control FSH (75%), GDF-9 (100) FSH
(60.9%) and GDF-9 (200) FSH (60.6%)).
4. Discussion
This study quantiﬁed GDF-9 mRNA and its effect on the
in vitro culture of caprine preantral follicles. The mRNA
quantiﬁcation revealed an increase in the GDF-9 mRNA
expression, as follicular growth progressed, during the pre-
antral phase. Silva et al. (2004) showed the presence of
mRNA and the GDF-9 ligand and receptor proteins in all
of the categories of the caprine ovarian follicles. However,
it was not clear if the expression pattern of this factor var-
ied during follicular development. In this study, secondary
follicles showed an elevated GDF-9 mRNA expression level,
when compared to the primordial and primary follicles.
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Based on these ﬁndings, it was decided to test the
ffect of GDF-9 on secondary follicles, and the impor-
ance was conﬁrmed via in vitro follicular development. It
as observed that the COC’s expressed signiﬁcantly more
RNA, than did the granulosa/theca cells. This expres-
ion proﬁle may  be related to the oocyte contribution,
hich is the main source of GDF-9 in the COC’s. Prochazka
t al. (2004) observed that prepubertal gilt oocytes within
rowing follicles express four times more GDF-9 mRNA
han the respective mural theca and granulosa cells. Using
ybridization techniques, the presence of GDF-9 mRNA
as exclusively conﬁrmed in oocytes for all of the follic-
lar stages in humans, except in the primordial follicles
McGrath et al., 1995).
Previous work performed by the group showed that
DF-9, at a concentration of 200 ng/mL, stimulated caprine
rimordial follicle activation and its progression to the
econdary follicle stage, during in situ culture for 7 days
Martins et al., 2008). The current work here has demon-
trated for the ﬁrst time, the inﬂuence of GDF-9 on the
n vitro development of isolated caprine secondary follicles
uring long-term culture (18 days). GDF-9, at a concen-
ration of 100 ng/mL and without FSH, favored follicular
urvival, compared to the control group (Experiment 2). In
umans, during the in vitro culture of preantral follicles
nclosed in ovarian tissue, GDF-9 promoted follicular via-
ility for 14 days and the progression from primordial and
rimary follicles, to the secondary stage (Hreinsson et al.,
002).
When FSH was not added to the basic culture medium
Experiment 2), the addition of GDF-9 (100 ng/mL) effec-
ively stimulated follicular growth. However, although a
ositive effect of GDF-9 on follicular growth was recorded,
t did not affect the percentage of oocytes that were
110 m in diameter and destined for IVM. Thus it did
ot inﬂuence the oocyte growth rate. This fact suggests
hat GDF-9 predominantly promoted follicular growth, by
timulating granulosa cell proliferation. In fact, GDF-9 stim-
lates granulosa cell proliferation and the differentiation
n preantral follicles and small antral follicles of immature
ats (Vitt et al., 2000) and humans (Hreinsson et al., 2002)
 which may  explain the results achieved.
In addition, the increase in GDF-9 mRNA expression
n the secondary follicles observed in this study, conﬁrms
he importance of this factor for caprine ovarian follicular
evelopment. Other research has highlighted the impor-
ance of GDF-9 regarding follicular growth, as this factor
timulated the growth of the primordial follicles in ham-
ters (Wang. and Roy, 2004), granulosa cell proliferation in
mmature rats (Vitt et al., 2000) and secondary follicular
rowth (130–150 m)  in rats (Hayashi et al., 1999).
In Experiment 2 (basic medium without FSH), no differ-
nces were recorded between the treatments in antrum
ormation. Similar results were recorded in the culture
f caprine preantral follicles in a medium without FSH –
hich demonstrates that FSH is not essential for antrum
ormation during the in vitro culture of secondary follicles
Saraiva et al., 2010).
The GDF-9 positive effects (Experiment 2) on follicular
urvival and development were not recorded, when FSH
as added (Experiment 3). Hayashi et al. (1999) recordedesearch 100 (2011) 169– 176 175
that GDF-9 and FSH, alone or in combination, favored
isolated preantral follicles of immature rats. It has been
conﬁrmed that FSH may  act on preantral follicular growth
in goats (Matos et al., 2007; Magalhães et al., 2009), sheep
(Campbell et al., 2004), cows (Gutierrez et al., 2000; Itoh
et al., 2002) and mice (Cortvrindt et al., 1997). Thus, FSH
is an important survival and follicular growth factor that
stimulates the production of the different intra-ovarian
growth factors (Thomas et al., 2005). Hence, a possible
explanation for the absence of any signiﬁcant effect of GDF-
9 in the presence of FSH, is that this gonadotrophin may
induce the expression of intra-ovarian factors – inhibit-
ing any additional effects of GDF-9. However, FSH may
also inhibit GDF-9, by regulating the expression of spe-
ciﬁc receptors (BMPRII and ALK-5) as was observed in ovine
isolated granulosa cell culture (Qin Chen et al., 2009).
In caprine species, the production of fully grown oocytes
from preantral follicle in vitro culture capable of restarting
meiosis is a rare event (Silva et al., 2010). In the current
research, oocytes capable of resuming meiosis and com-
pleting in vitro nuclear maturation (metaphase II), were
obtained for the ﬁrst time. Although this is progress in
caprine preantral follicle culture, the IVM rates recorded
were minimal and not affected by the treatments.
Based on these results, GDF-9 is essential for the regula-
tion of caprine follicular development. Its respective mRNA
is expressed during all the follicular stages and it also has
a positive effect on follicular survival, precocity of antrum
formation and production of oocytes, capable of restart-
ing meiosis. Future studies are necessary to improve the
maturation rates of oocytes from in vitro grown caprine
preantral follicles.
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